5. References
- IBM Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu/ (cited: June 20, 2022).
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2022. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu. Accessed June 20, 2022.
- Aspirin extended-release capsules (Durlaza®) package insert. New Haven Pharmaceuticals, September 2015.
- Diclofenac potassium powder for solution (Cambia®) package insert. Assertio Therapeutics, Inc. October 2019.
- Diclofenac potassium tablet (Lofena®) package insert. Carwin Pharmaceutical Associates, LLC. November 2021.
- Diclofenac potassium tablet (Cataflam®) package insert. Blucrest Pharmaceuticals, LLC. July 2021.
- Diclofenac potassium tablets package insert. Mylan Pharmaceuticals, October 2020.
- Diclofenac potassium liquid filled capsule (Zipsor®) package insert. Assertio Therapeutics, Inc. April 2021.
- Diclofenac capsules (Zorvolex®) package insert. Iroko Pharmaceuticals, LLC, April 2019.
- Diflunisal oral tablet package insert. Cadila Healthcare Limited. December 2019.
- Etodolac tablets and capsules package insert. Taro Pharmaceuticals U.S.A., Inc. March 2021.
- Etodolac extended-release tablets package insert. Northstar RX LLC. May 2021.
- Fenoprofen calcium oral capsule (Nalfon®) package insert. Xspire Pharma. May 2021.
- Fenoprofen calcium oral tablet (Nalfon®) package insert. Xspire Pharma. May 2021.
- Flurbiprofen oral tablet package insert. Teva Pharmaceuticals USA, Inc. November 2021.
- Ibuprofen oral tablets product information. Aero Healthcare. April 2022.
- Indomethacin oral capsule package insert. Cadila Healthcare Limited. August 2021.
- Indomethacin capsules (Tivorbex®) package insert. Iroko Pharmaceuticals, LLC, January 2018.
- Indomethacin (Indocin®) package insert. Zyla Life Sciences US Inc. November 2021.
- Ketoprofen oral capsule package insert. Misemer Pharmaceuticals, Inc. January 2022.
- Ketoprofen extended release oral capsule package insert. Mylan Pharmaceuticals Inc. March 2021.
- Meclofenamate oral capsule package insert. Mylan Pharmaceuticals Inc. May 2021.
- Mefenamic acid capsules package insert. Belcher Pharmaceuticals, LLC. December 2021.
- Meloxicam oral tablet (Mobic ®) package insert. Boehringer Ingelheim Pharmaceuticals, Inc. October 2018.
- Meloxicam capsules (Vivlodex®) package insert. Egalet US Inc. April 2021.
- Nabumetone oral tablet (Relafen®) package insert. Blucrest Pharmaceuticals LLC. July 2021.
- Nabumetone oral tablet (Relafen DS®) package insert. Carwin Pharmaceutical Associates, LLC. May 2022.
- Naproxen delayed-release tablets (EC-Naprosyn®), naproxen tablets (Naprosyn®), naproxen sodium tablets (Anaprox®/Anaprox® DS) package insert. Atnahs Pharma US. March 2017.
- Naproxen sodium controlled-release tablets (Naprelan®) package insert. Almatica Pharma. April 2021.
- Oxaprozin caplets (Daypro®) package insert. Pfizer. January 2022.
- Piroxicam oral capsules (Feldene®) package insert. Pfizer. May 2021.
- Salsalate oral tablet package insert. Acella Pharmaceuticals, LLC. January 2020.
- Sulindac oral tablet package insert. Actavis Pharma, Inc. September 2021.
- Diclofenac sodium/misoprostol tablets (Arthrotec®) package insert. Pfizer. August 2021.
- Ibuprofen and famotidine oral tablet (Duexis®) package insert. Horizon Therapeutics USA, Inc. June 2021.
- Naproxen and esomeprazole magnesium oral tablet (Vimovo®) package insert. Horizon Therapeutics USA, Inc. March 2022.
- Ketorolac (Toradol®) package insert. Roche Pharmaceuticals. March 2013.
- Children’s ibuprofen suspension (100 mg/5 ml) product information. Amazon.com Services LLC. November 2021.
- AHFS Drug Information 2022. Bethesda, MD: American Society of Health-System Pharmacists. 2022. Available at: http://online.statref.com.ezproxy.lib.utexas.edu/document/F9-IjOEqk3ZluRgZSvZvmt!!. Accessed June 20, 2022.
- Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-150.
- U.S. Food and Drug Administration. Center for Drug Evaluation and Research. COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). (February 6, 2018) Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cox-2-selective-includes-bextra-celebrex-and-vioxx-and-non-selective-non-steroidal-anti-inflammatory. Accessed June 20, 2022.
- United States Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. (July 9, 2015) Available at: http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm. Accessed June 20, 2022.
- Joshi GP, Gertler R, Fricker R. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Anesth Analg. 2007;105:1793–804.
- Waksman JC, Brody A, Phillips SD. Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? Ann Pharmacother. 2007;41:1163-73.
- Hermann M, Ruschitzka F. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs. Ann Med. 2007;39:18-27.
- Friedewald VE, Bennett JS, Christo JP, et al. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010;106(6):873-84.
- Lazzaroni M, Battocchia A, Porro GB. COXIBs and non-selective NSAIDs in the gastroenterological setting: What should patients and physicians do? Dig Liver Dis. 2007;39:589-96.
- Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized trial. JAMA. 2000;284;1247-55.